Tuxin Pharmaceutical (301089.SZ)'s application for issuing shares to specific targets approved by Shenzhen Stock Exchange review

Zhitong Finance APP News, Tuoxin Pharmaceutical (301089.SZ) issued an announcement that on November 1, 2026, the company received the "Notification Letter of the Review Center's Opinions on the Application of Tuoxin Pharmaceutical Group Co., Ltd. for Issuing Shares to Specific Targets" issued by the Shenzhen Stock Exchange. The Shenzhen Stock Exchange's issuance and listing review institution reviewed the company's application documents for issuing shares to specific targets and considered that the company meets the issuance conditions, listing conditions, and information disclosure requirements. Subsequently, the Shenzhen Stock Exchange will, in accordance with regulations, submit the matter to the China Securities Regulatory Commission to carry out the relevant registration procedures.